Compounds
The present invention provides organic compounds of the following structure;A-L1-B-C-D-L2-Ethat are useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.
Novartis AG
C A A A A A A A A A A C A A A A C C A A A C A A A C C A A C A A A C A A A A A A C C A A A A A A A C
C07D A61K A61P A61P A61P A61P A61P A61K A61P A61P A61P C07D A61P A61K A61K A61K C07D C07D A61P A61P A61K C07D A61K A61P A61P C07D C07D A61P A61P C07D A61K A61P A61P C07D A61K A61P A61P A61P A61P A61P C07D C07D A61P A61P A61K A61K A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Young-Shin Wenming Michael H.
Kwak Liu Serrano-Wu